×

Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia. Hwang SM, Kim SM, Nam Y et al. Leuk Res. 2019 (84): 106190.

ImmunoglobulinG4-related disease mimicking lymphoma. SM Hwang, JH Paik, JY Lee. Ann Hematol 2019 (98): 2239-2241.

Application of Fluorescence in situ hybridization on cerebrospinal fluid cytospins for the detection of residual leukemia cells in patients with childhood acute lymphoblastic leukemia. Hwang SM, Park HS, Park S, et al. Am J Clin Pathol. 2019 (151):416-23.

Are clonal cells circulating in the peripheral blood of myelodysplastic syndrome?: Quantitative comparison between bone marrow and peripheral blood by targeted gene sequencing and fluorescence in situ hybridization. Hwang SM, Im K, Chang YH, et al. Leuk Res. 2018 Aug;71:92-94.

Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in BRCA1 and BRCA2. Hwang SM, Lee KC, Lee MS, Park KU. Cancer Res Treat. 2018 Jan;50(1):255-264.

Dysregulation of Telomere Lengths and Telomerase Activity in Myelodysplastic Syndrome. Park HS, Choi J, See CJ, Kim JA, Park SN, Im K, Kim SM, Lee DS, Hwang SM. Ann Lab Med. 2017 May;37(3):195-203.

Short telomere length and its correlation with gene mutations in myelodysplastic syndrome. Hwang SM, Kim SY, Kim JA, Park HS, Park SN, Im K, Kim K, Kim SM, Lee DS. J Hematol Oncol.

1: Risk of disease transformation and second primary solid tumors in patients with myeloproliferative neoplasms. Hong J, Lee JH, Byun JM, Lee JY, Koh Y, Shin DY, Lee JO, Hwang SM, Choi HS, Kim I, Yoon SS, Bang SM. Blood Adv. 2019 Nov 26;3(22):3700-3708.

2: Mutation of ten-eleven translocation-2 is associated with increased risk of autoimmune disease in patients with myelodysplastic syndrome. Oh YJ, Shin DY, Hwang SM, Kim SM, Im K, Park HS, Kim JA, Song YW, Marquez A, Martin J, Lee DS, Park JK. Korean J Intern Med. 2019 Oct 25

3: Differential disruption of autoinhibition and defect in assembly of cytoskeleton during cell division decide the fate of human DIAPH1-related cytoskeletopathy. Kim BJ, Ueyama T, Miyoshi T, Lee S, Han JH, Park HR, Kim AR, Oh J, Kim MY, Kang YS, Oh DY, Yun J, Hwang SM, Kim NKD, Park WY, Kitajiri SI, Choi BY. J Med Genet. 2019 Dec;56(12):818-827.

4: Prevalence of germline predisposition gene mutations in pediatric acute myeloid leukemia: Genetic background of pediatric AML. Jeong D, Kim N, Choi S, Kim K, Kim SM, Im K, Park HS, Yun J, Lim KM, Park KS, Kang HJ, Ahn YO, Hwang SM, Lee DS. Leuk Res. 2019 Oct;85:106210.

5: Characteristics of Waldenstrom Macroglobulinemia in Korean Patients According to Mutational Status of MYD88 and CXCR4: Analysis Using Ultra-Deep Sequencing. Shin DW, Kim SM, Kim JA, Park HS, Hwang SM, Im K, Kim S, Kim J, Kwon S, Yoon SS, Lee DS. Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):e496-e505.

6: ASXL1 is a molecular predictor in idiopathic cytopenia of undetermined significance. Shin DY, Park JK, Kim SM, Im K, Kim JA, Kim SY, Hwang SM, Yoon SS, Lee DS.Leuk Lymphoma. 2019 Mar;60(3):756-763.

7. Shifting of erythroleukemia to myelodysplastic syndrome according to the revised WHO classification: Biologic and cytogenetic features of shifted erythroleukemia. Ryu S, Park HS, Kim SM, Im K, Kim JA, Hwang SM, Yoon SS, Lee DS. Leuk Res. 2018 Jul;70:13-19.